Fresenius

Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Fresenius’ new CEO starts strategic review as pressure rises
Pharmaphorum
Mon, 10/31/22 - 10:19 am
Fresenius
Michael Sen
Pharma CEOs
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fierce Biotech
Fri, 10/9/20 - 11:00 am
diabetes
Fresenius
intensive care
extracorporeal care
dialysis
Fresenius to launch a mechanical ventilators alternative in U.S.
Mass Device
Tue, 02/25/20 - 10:35 am
Fresenius
devices
Novalung
mechanical ventilators
After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes
Fierce Pharma
Fri, 08/2/19 - 12:13 am
Akorn
Fresenius
Medtech's Biggest Deals in 2019 ... So Far
Medical Devices and Diagnostics Industry
Thu, 07/25/19 - 07:20 pm
devices
M&A
Hill-Rom
Voalte
Abbott Laboratories
Cephea Valve Technologies
ZOLL Medical
TherOx
Stryker
Arrinex
Medtronic
Epix Therapeutics
Guardant Health
Bellwether Bio
Titan Spine
Bosotn Scientific
Vertiflex
Edward Lifesciences
CAS Medical Systems
Fresenius
NxStage
JNJ
Auris Health
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Fierce Pharma
Mon, 12/10/18 - 07:02 pm
Akorn
Fresenius
M&A
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Fierce Pharma
Thu, 12/6/18 - 12:59 pm
Akorn
Fresenius
M&A
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Fierce Pharma
Mon, 10/1/18 - 02:31 pm
Akorn
Fresenius
M&A
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fierce Pharma
Tue, 02/27/18 - 11:33 am
Fresenius
Akorn
drug manufacturing
generics
data integrity
FDA
Fresenius oncology drug plant slammed with new warning letter
Fierce Pharma
Fri, 12/29/17 - 10:48 am
Fresenius
warnings
drug manufacturing
oncology
Fresenius closer and closer to marketing biosimilars
GoinPharma
Wed, 12/20/17 - 11:00 pm
Fresenius
biosimilars
Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
Endpoints
Wed, 11/22/17 - 10:03 am
open plan offices
Fresenius
hirings
The 10 largest medtech employers – and what their workers really think
Medical Design and Outsourcing
Fri, 09/15/17 - 11:16 am
devices
employees
Baxter
B. Braun
Boston Scientific
Cardinal Health
Essilor
Fresenius
GE Healthcare
Medtronic
Philips
Stryker
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fri, 09/1/17 - 11:08 am
Fresenius
Merck KGaA
biosimilars
M&A
NxStage Medical Acquired by Fresenius for $2 Billion
TheStreet.com
Mon, 08/7/17 - 09:56 pm
Fresenius
NxStage Medical
M&A
dialysis
devices
How Trump’s First 100 Days Affected the Healthcare Industry
Motley Fool
Tue, 05/2/17 - 10:10 am
Donald Trump
Express Scripts
Anthem
insurers
Akorn
Fresenius
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
Tue, 04/25/17 - 11:22 am
M&A
generics
Fresenius
Akorn
Big Pharma has become a leader in the fight against the death penalty
Yahoo/Business Insider
Mon, 04/17/17 - 11:24 am
Big Pharma
execution drugs
McKesson
Pfizer
Fresenius
West-Ward Pharmaceuticals

Pages